VOLATO GROUP INC (SOAR)

US74349W1045 - Common Stock

0.2433  +0.01 (+5.46%)

After market: 0.2481 +0 (+1.97%)

Fundamental Rating

0

We assign a fundamental rating of 0 out of 10 to SOAR. SOAR was compared to 23 industry peers in the Passenger Airlines industry. SOAR has a bad profitability rating. Also its financial health evaluation is rather negative. SOAR does not seem to be growing, but still is valued expensively.



0

1. Profitability

1.1 Basic Checks

SOAR had negative earnings in the past year.
In the past year SOAR has reported a negative cash flow from operations.

1.2 Ratios

The Return On Assets of SOAR (-194.31%) is worse than 91.30% of its industry peers.
Industry RankSector Rank
ROA -194.31%
ROE N/A
ROIC N/A
ROA(3y)-24.42%
ROA(5y)N/A
ROE(3y)-119.23%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

SOAR does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

1

2. Health

2.1 Basic Checks

SOAR does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, SOAR has less shares outstanding
SOAR has a worse debt/assets ratio than last year.

2.2 Solvency

SOAR has an Altman-Z score of -4.75. This is a bad value and indicates that SOAR is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of SOAR (-4.75) is worse than 86.96% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -4.75
ROIC/WACCN/A
WACC11.75%

2.3 Liquidity

SOAR has a Current Ratio of 0.66. This is a bad value and indicates that SOAR is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.66, SOAR is in line with its industry, outperforming 52.17% of the companies in the same industry.
SOAR has a Quick Ratio of 0.66. This is a bad value and indicates that SOAR is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.66, SOAR perfoms like the industry average, outperforming 56.52% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.66
Quick Ratio 0.66

0

3. Growth

3.1 Past

SOAR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -9883.52%.
EPS 1Y (TTM)-9883.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-25%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

SOAR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for SOAR!.
Industry RankSector Rank
Dividend Yield N/A

VOLATO GROUP INC

NYSEARCA:SOAR (12/18/2024, 8:04:00 PM)

After market: 0.2481 +0 (+1.97%)

0.2433

+0.01 (+5.46%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryPassenger Airlines
Earnings (Last)05-15 2024-05-15/bmo
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners50.26%
Ins Owner Change0.98%
Market Cap7.25M
AnalystsN/A
Price TargetN/A
Short Float %2.16%
Short Ratio0.02
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.05
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-4.89
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1.35
FCFYN/A
OCF(TTM)-1.33
OCFYN/A
SpS4.77
BVpS-0.66
TBVpS-0.73
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -194.31%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-24.42%
ROA(5y)N/A
ROE(3y)-119.23%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover2.96
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.66
Quick Ratio 0.66
Altman-Z -4.75
F-Score4
WACC11.75%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-9883.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-25%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-1659.94%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1756.27%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1720.23%
OCF growth 3YN/A
OCF growth 5YN/A